Gold nanoparticles as amyloid-like fibrillogenesis inhibitors

Colloids and Surfaces B: Biointerfaces

Volumn 112, Issue , 2013, Pages 525-529

  Hsieh, Shuchen ^a   Chang, Chiung wen ^a   Chou, Hsuan hung ^a  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

AFM; Alzheimer's; Amyloid fibril; Insulin; Nanoparticle

Indexed keywords

AFM; ALZHEIMER'S; AMYLOID FIBRIL; ANTI-DIABETIC DRUGS; BLOOD-BRAIN BARRIER; INDISPENSABLE TOOLS; STRUCTURAL TRANSFORMATION; THERAPEUTIC EFFECTS;

AGGLOMERATION; DIAGNOSIS; DRUG DELIVERY; GOLD; INSULIN; METAL NANOPARTICLES; NANOPARTICLES; NEURODEGENERATIVE DISEASES;

GLYCOPROTEINS;

AMYLOID; GOLD NANOPARTICLE; INSULIN; PROTEINASE;

ALPHA HELIX; ARTICLE; BETA SHEET; BINDING AFFINITY; BIOSYNTHESIS; CONFORMATIONAL TRANSITION; FIBRILLOGENESIS; PH; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FIBRILLATION; PROTEIN INTERACTION; PROTEIN PROCESSING; PROTEIN STABILITY;

AFM; ALZHEIMER'S; AMYLOID FIBRIL; INSULIN; NANOPARTICLE;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; BLOOD-BRAIN BARRIER; CATTLE; CIRCULAR DICHROISM; DRUG DELIVERY SYSTEMS; GOLD; HUMANS; INSULIN; METAL NANOPARTICLES; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; PROTEIN MULTIMERIZATION;

EID: 84887019016     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.08.029     Document Type: Article

References (28)

1. Librizzi F., Rischel C. The kinetic behavior of insulin fibrillation is determined by heterogeneous nucleation pathways. Protein Sci. 2005, 14:3129-3134.
2. Kelly J.W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 1998, 8:101-106.
3. Dobson C.M. The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. B 2001, 356:133-145.
4. Gerich J.E. The genetic basis of type 2 diabetes mellitus: impaired insulin secretion versus impaired insulin sensitivity. Endocr. Rev. 1998, 19:491-503.
5. Reaven G. Insulin resistance, type 2 diabetes mellitus, and cardiovascular disease: the end of the beginning. Circulation 2005, 112:3030-3032.
6. de la Monte S.M., Wands J.R. Alzheimer's disease is type 3 diabetes-evidence reviewed. J. Diab. Sci. Technol. 2008, 2:1101-1113.
7. de la Monte S.M. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr. Alzheimer Res. 2012, 9:35-66.
8. Akter K., Lanza E.A., Martin S.A., Myronyuk N., Rua M., Raffa R.B. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?. Br. J. Clin. Pharmacol. 2011, 71:365-376.
9. Boado R.J. Antisense drug-delivery through the blood-brain-barrier. Adv. Drug Deliv. Rev. 1995, 15:73-107.
10. Kanwar J.R., Sun X., Punj V., Sriramoju B., Mohan R.R., Zhou S.F., Chauhan A., Kanwar R.K. Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal. Nanomedicine 2012, 8:399-414.
11. Salata O. Applications of nanoparticles in biology and medicine. J. Nanobiotechnol. 2004, 2:3.
12. Patil S.D., Rhodes D.G., Burgess D.J. DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J. 2005, 7:E61-E77.
13. Torchilin V.P. Multifunctional nanocarriers. Adv. Drug Deliv. Rev. 2006, 58:1532-1555.
14. El-Sayed I.H., Huang X., El-Sayed M.A. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett. 2005, 5:829-834.
15. El-Sayed I.H., Huang X., El-Sayed M.A. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett. 2006, 239:129-135.
16. Tiwari P., Vig K., Dennis V., Singh .S. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 2011, 1:31-63.
17. Zhuang Z.P., Kung M.P., Hou C., Skovronsky D.M., Gur T.L., Plossl K., Trojanowski J.Q., Lee V.M., Kung H.F. Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J. Med. Chem. 2001, 44:1905-1914.
18. Smith Q.R. A review of blood-brain barrier transport techniques. Methods Mol. Med. 2003, 89:193-208.
19. Yoo S.I., Yang M., Brender J.R., Subramanian V., Sun K., Joo N.E., Jeong S.H., Ramamoorthy A., Kotov N.A. Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: functional similarities with proteins. Angew. Chem. Int. Ed. 2011, 50:5110-5115.
20. Agyare E.K., Curran G.L., Ramakrishnan M., Yu C.C., Poduslo J.F., Kandimalla K.K. Development of a smart nano-vehicle to target cerebrovascular amyloid deposits and brain parenchymal plaques observed in Alzheimer's disease and cerebral amyloid angiopathy. Pharm. Res. 2008, 25:2674-2684.
21. Cabaleiro-Lago C., Quinlan-Pluck F., Lynch I., Lindman S., Minogue A.M., Thulin E., Walsh D.M., Dawson K.A., Linse S. Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J. Am. Chem. Soc. 2008, 130:15437-15443.
22. Cheng S.F., Chau L.K. Colloidal gold-modified optical fiber for chemical and biochemical sensing. Anal. Chem. 2003, 75:16-21.
23. Jansen R., Dzwolak W., Winter R. Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy. Biophys. J. 2005, 88:1344-1353.
24. Hsieh C.W., Hsieh S. Nanoparticle chain formation on functional surfaces using insulin fibrils as a structure directing agent. J. Mater. Chem. 2011, 21:16900-16904.
25. Kogan M.J., Bastus N.G., Amigo R., Grillo-Bosch D., Araya E., Turiel A., Labarta A., Giralt E., Puntes V.F. Nanoparticle-mediated local and remote manipulation of protein aggregation. Nano Lett. 2006, 6:110-115.
26. Araya E., Olmedo I., Bastus N., Guerrero S., Puntes V., Giralt E., Kogan M. Gold Nnanoparticles and microwave irradiation inhibit beta-amyloid amyloidogenesis. Nanoscale Res. Lett. 2008, 3:435-443.
27. Lee K.H., Ytreberg F.M. Effect of gold nanoparticle conjugation on peptide dynamics and structure. Entropy 2012, 14:630-641.
28. Hsieh S.C., Hsieh C.W. Alignment of gold nanoparticles using insulin fibrils as a sacrificial biotemplate. Chem. Commun. 2010, 46:7355-7357.